HAVCR2 and B-cell chronic lymphocytic leukemia: Our findings showed that Tim-3 expression was not significantly different in CLL patients in comparison with healthy controls (p = 0.123, Figure 2A), but Fyn expression was significantly decreased in CLL patients (p = 0.009, Figure 2B).